Brief, High-dose rTMS for Depression
NCT: NCT04657432 · ACTIVE_NOT_RECRUITING
Brief Summary
High frequency repetitive transcranial magnetic stimulation (rTMS) has been shown to be safe, feasible, and acceptable. Conventionally, rTMS investigations have relied on rational decision trees for dosage determination. The purpose of this study is to systematically examine an accelerated protocol of intermittent theta burst (iTBS). Study 1 aims to provide a quantifiable dose-response curve for iTBS and depressive symptom reduction in major depression. Study 2 aims to determine the role of individual variations of their functional networks compared to the site of stimulation and clinical outcomes.
Frequently Asked Questions
What is Brief, High-dose rTMS for Depression?
Brief, High-dose rTMS for Depression is a clinical trial registered under NCT04657432. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04657432?
The current status of NCT04657432 (Brief, High-dose rTMS for Depression) is: ACTIVE_NOT_RECRUITING.
When did Brief, High-dose rTMS for Depression start?
Brief, High-dose rTMS for Depression started on 2021-05-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.